Cite
MLA Citation
R Atreya et al.. “P548 Efficacy outcomes of placebo maintenance treatment in patients with moderate to severe Crohn's disease who responded to placebo induction therapy: Post-hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Risankizumab Studies.” Journal of Crohn's and colitis, vol. 17, n.d., pp. i675–i677. http://access.bl.uk/ark:/81055/vdc_100179844218.0x00002f